Illumina, Inc.
ILMN
|
$117.87
-2.72%
630K
|
Health Technology
(0.0% 1d) (-1.8% 1m) (-44.4% 1y) (0.0% 2d) (0.0% 3d) (-2.6% 7d) (NaN% volume)
Earnings Calendar: 2024-02-08
Market Cap: $ 18,771,432,230
http://www.illumina.com
Sec Filling | Patents | 7700 employees
(US) Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
genomic genetic
add to watch list Paper trade email alert is off
Press-releases
Multicancer Screening Market Projected to Reach $2.72 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-16 (Crawled : 03:00) - prnewswire.com
LH | $203.85 0.26% 130K
|
Health Services
|
| O: -2.09%
H: 0.0%
C: 0.0%
ILMN | $117.87 -2.72% 630K
|
Health Technology
|
| O: -7.42%
H: 0.0%
C: 0.0%
GH | $16.215 -4.95% 510K
|
Health Services
|
| O: -8.95%
H: 0.0%
C: 0.0%
report reach market
Illumina's planned divestment of GRAIL approved by the European Commission
Published: 2024-04-12 (Crawled : 13:00) - prnewswire.com
ILMN | $117.87 -2.72% 630K
|
Health Technology
|
| O: -1.3%
H: 4.53%
C: -1.5%
approved
Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer
Published: 2024-04-09 (Crawled : 20:00) - prnewswire.com
SMMT | $3.5 -4.5% 360K
|
Health Technology
|
| O: -3.87%
H: 5.05%
C: 1.99%
ILMN | $117.87 -2.72% 630K
|
Health Technology
|
| O: -3.49%
H: 2.66%
C: 1.76%
CDNA 4 | $7.975 -2.74% 200K
|
Health Technology
|
| O: -5.53%
H: 0.96%
C: -1.49%
financial
Companion Diagnostics Market Worth $13.6 billion | MarketsandMarkets™
Published: 2024-04-05 (Crawled : 14:30) - prnewswire.com
TMO | $555.75 -0.38% 380K
|
Health Technology
|
| O: -1.7%
H: 2.39%
C: 1.62%
A | $137.91 -1.65% 650K
|
Health Technology
|
| O: 2.01%
H: 0.92%
C: -0.04%
MYGN F | $19.0 -0.89% 95K
|
Health Technology
|
| O: -0.64%
H: 2.19%
C: 0.85%
ILMN | $117.87 -2.72% 630K
|
Health Technology
|
| O: -0.75%
H: 3.52%
C: 2.16%
ICLR | $295.56 -1.19% 260K
|
Health Technology
|
| O: 0.31%
H: 2.54%
C: 1.49%
companion diagnostics market
Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024
Published: 2024-04-04 (Crawled : 21:00) - prnewswire.com
ILMN | $117.87 -2.72% 630K
|
Health Technology
|
| O: -0.75%
H: 3.52%
C: 2.16%
first financial results
DNA Methylation Detection Technology Markets, 2033 - Intensified Competition, Increasing Adoption, PCR Dominates
Published: 2024-03-30 (Crawled : 04:20) - prnewswire.com
ABCM | $23.99 0.0% 7.4M
|
Health Technology
| Email alert
Add to watchlist
EXAS | $64.285 -1.63% 1.8M
|
Health Technology
| Email alert
Add to watchlist
HOLX | $75.77 -2.28% 250K
|
Health Technology
| Email alert
Add to watchlist
ILMN | $117.87 -2.72% 630K
|
Health Technology
| Email alert
Add to watchlist
PACB | $1.525 -46.21% 30M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $39.37 -0.76% 330K
|
Health Technology
| Email alert
Add to watchlist
A | $137.91 -1.65% 650K
|
Health Technology
| Email alert
Add to watchlist
BIO | $295.38 -1.67% 72K
|
Health Technology
| Email alert
Add to watchlist
PKI | $115.24 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $39.37 -0.76% 330K
|
Health Technology
| Email alert
Add to watchlist
ABCZF | $22.1 -2.32% 4K
|
Health Technology
| Email alert
Add to watchlist
dna technology
Global Sample Preparation Market Analysis and Outlook 2023-2030 Featuring Profiles of Agilent Technologies, Bio-Rad Labs, Danaher Corp, Illumina, Merck, and Other Key Players
Published: 2024-03-29 (Crawled : 11:00) - prnewswire.com
ILMN | $117.87 -2.72% 630K
|
Health Technology
| Email alert
Add to watchlist
QGEN | $39.37 -0.76% 330K
|
Health Technology
| Email alert
Add to watchlist
A | $137.91 -1.65% 650K
|
Health Technology
| Email alert
Add to watchlist
BIO | $295.38 -1.67% 72K
|
Health Technology
| Email alert
Add to watchlist
DHR | $240.78 0.47% 1.3M
|
Health Technology
| Email alert
Add to watchlist
PKI | $115.24 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $39.37 -0.76% 330K
|
Health Technology
| Email alert
Add to watchlist
TMO | $555.75 -0.38% 380K
|
Health Technology
| Email alert
Add to watchlist
global key market
In Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarkets™
Published: 2024-03-27 (Crawled : 14:30) - prnewswire.com
QGEN | $39.37 -0.76% 330K
|
Health Technology
|
| O: 0.02%
H: 0.28%
C: 0.09%
DHR | $240.78 0.47% 1.3M
|
Health Technology
|
| O: 0.56%
H: 0.16%
C: -0.43%
BIO | $295.38 -1.67% 72K
|
Health Technology
|
| O: 0.62%
H: 2.18%
C: 2.02%
BDX | $232.97 -0.75% 330K
|
Health Technology
|
| O: 0.57%
H: 1.36%
C: 1.34%
A | $137.91 -1.65% 650K
|
Health Technology
|
| O: 0.86%
H: 1.26%
C: 1.18%
ABT | $109.92 0.95% 3.2M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
SRDX | $26.9 -0.37% 6.6K
|
Health Technology
|
| O: 0.99%
H: 2.11%
C: 1.09%
QGEN | $39.37 -0.76% 330K
|
Health Technology
|
| O: 0.02%
H: 0.28%
C: 0.09%
ILMN | $117.87 -2.72% 630K
|
Health Technology
|
| O: 1.28%
H: 2.34%
C: 2.34%
HOLX | $75.77 -2.28% 250K
|
Health Technology
|
| O: 0.56%
H: 1.01%
C: 0.98%
AXDX M | $0.91 4.1K
|
Health Technology
|
| O: 4.13%
H: 1.0%
C: 1.0%
diagnostics market
North America Molecular Diagnostics Analysis Report 2024: Market to Reach $7.23 Billion by 2030, Driven by Early Disease Detection, External Funding, and Strategic Partnerships
Published: 2024-03-27 (Crawled : 02:00) - prnewswire.com
TMO | $555.75 -0.38% 380K
|
Health Technology
|
| O: 0.65%
H: 1.27%
C: 1.2%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
BIO | $295.38 -1.67% 72K
|
Health Technology
|
| O: 0.62%
H: 2.18%
C: 2.02%
A | $137.91 -1.65% 650K
|
Health Technology
|
| O: 0.86%
H: 1.26%
C: 1.18%
ILMN | $117.87 -2.72% 630K
|
Health Technology
|
| O: 1.28%
H: 2.34%
C: 2.34%
AXDX M | $0.91 4.1K
|
Health Technology
|
| O: 4.13%
H: 1.0%
C: 1.0%
america disease report reach diagnostics molecular market
GRAIL Presents New Data on Galleri® and Its Methylation Platform at the Annual American Association for Cancer Research (AACR) Meeting
Published: 2024-03-27 (Crawled : 23:00) - biospace.com/
ILMN | $117.87 -2.72% 630K
|
Health Technology
|
| O: 1.28%
H: 2.34%
C: 2.34%
galleri association cancer research meeting platform
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 53% | 47% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
Last 48 Hours Insiders Buying
RVP P 3587 | $1.06 -1.85% 21K
|
Health Technology
|
17:00
TPL P 12 | $588.26 0.75% 12K
|
Miscellaneous
|
16:01
HNRA | $2.617 10.89% 260K
|
n/a
|
15:02
TGEN | $0.67 16K
|
Utilities
|
14:30
RMCF | $3.6492 9.1K
|
Consumer Non-Durables
|
20:10